{"id":6131,"date":"2022-09-18T12:50:24","date_gmt":"2022-09-18T08:20:24","guid":{"rendered":"http:\/\/arasto.com\/product\/nortriptyline-hcl\/"},"modified":"2023-05-06T12:13:09","modified_gmt":"2023-05-06T08:43:09","slug":"nortriptyline-hcl","status":"publish","type":"product","link":"https:\/\/arasto.com\/fa\/product\/nortriptyline-hcl\/","title":{"rendered":"Nortriptyline HCl"},"content":{"rendered":"<p dir=\"ltr\"><strong>Description<\/strong><\/p>\n<p dir=\"ltr\">(USP44\/BP2022)<\/p>\n<ol dir=\"ltr\">\n<li><strong>Drug Substance General Information (ICH 3.2.S.1)<\/strong><\/li>\n<\/ol>\n<p dir=\"ltr\"><strong>1.1. Nomenclature (ICH 3.2.S.1.1)<\/strong><\/p>\n<p dir=\"ltr\">International Non-proprietary Name: Nortriptyline hydrochloride (Brand Name: Sensoval, Aventyl,\u00a0Pamelor, Norpress, Allegron, Noritren and Nortrilen)<\/p>\n<p dir=\"ltr\">Compendial name:\u00a0 Nortriptyline Hydrochloride<\/p>\n<p dir=\"ltr\">Chemical name:\u00a0 1-Propanamine, 3-(10,11-dihydro-5<em>H<\/em>-dibenzo[<em>a<\/em>,<em>d<\/em>]cyclohepten-5-ylidene)-<em>N<\/em>-methyl-,hydrochloride;\u00a0 10, 11-Dihydro-<em>N<\/em>-methyl-5<em>H<\/em>-dibenzo [<em>a<\/em>,<em>d<\/em>] cycloheptene-\u0394<sup>5<\/sup>,\u03b3-propylamine hydrochloride<\/p>\n<p dir=\"ltr\">Arasto\u2019s code: NOR<\/p>\n<p dir=\"ltr\">CAS Registry Number:\u00a0[894-71-3]<\/p>\n<ol dir=\"ltr\">\n<li><strong>Drug Substance General Information (ICH 3.2.S.1)<\/strong><\/li>\n<\/ol>\n<p dir=\"ltr\"><strong>1.2. Structure (ICH 3.2.S.1.2)<\/strong><\/p>\n<p dir=\"ltr\"><img loading=\"lazy\" decoding=\"async\" width=\"384\" height=\"278\" class=\"wp-image-6441 aligncenter\" src=\"https:\/\/arasto.com\/wp-content\/uploads\/2022\/09\/word-image-5768-1.png\" srcset=\"https:\/\/arasto.com\/wp-content\/uploads\/2022\/09\/word-image-5768-1.png 384w, https:\/\/arasto.com\/wp-content\/uploads\/2022\/09\/word-image-5768-1-300x217.png 300w\" sizes=\"auto, (max-width: 384px) 100vw, 384px\" \/><\/p>\n<p dir=\"ltr\">Empirical formula: C<sub>19<\/sub>H<sub>21<\/sub>N. HCl<\/p>\n<p dir=\"ltr\">Molecular Weight: 299.84 g\/mol<\/p>\n<ol dir=\"ltr\">\n<li><strong>Drug Substance General Information (ICH 3.2.S.1)<\/strong><\/li>\n<\/ol>\n<p dir=\"ltr\"><strong>\u00a01.3. General Properties (ICH 3.2.S.1.3)<\/strong><\/p>\n<p dir=\"ltr\">Nortriptyline hydrochloride is a white crystalline substance.\u00a0 It is administered orally for the treatment of depression.\u00a0 Nortriptyline hydrochloride is soluble in water and polar organic solvents such as alcohols, as DMF and DMSO.\u00a0 The pK<sub>a<\/sub>\u00a0of the secondary amine function is 9.7 (C. Hantsch, et al.\u00a0 Comprehensive Medicinal Chemistry, Vol. 6, New York, Pergamon Press, 1990) and its log P has been reported to be 4.3 (http:\/\/pharmacycode.com\/ Nortriptyline _Hcl.htm). \u00a0It is stable in acid and base (see Stability Studies).\u00a0\u00a0\u00a0 Acute oral LD<sub>50<\/sub>: has been reported to be mouse: PO. 327 mg\/kg, IV 25.7 mg\/kg, SC. 145 mg\/kg, and rat: PO 5012 mg\/kg,\u00a0 IV 22.3 mg\/kg, SC. 666 mg\/kg (\u00a0<a href=\"http:\/\/www.scienedirect\/\">http:\/\/www.scienedirect<\/a>.com\/Science).<\/p>\n<p dir=\"ltr\">The determination of purity and assay of APIs require comparison of the product with their respective Reference Standards (RS) and Related Compounds (RC or known impurities).\u00a0 Accordingly, ICH regulations on the purity and assay of reference standard and related compounds are clearly defined and must be followed by drug substance and drug product manufacturers.<\/p>\n<p dir=\"ltr\">According to ICH Q7, 11.1 there are 3 types of standards.\u00a0 This is summarized in the following chart and discussed in detail below.<\/p>\n<p dir=\"ltr\"><img loading=\"lazy\" decoding=\"async\" width=\"500\" height=\"482\" class=\"wp-image-6443 aligncenter\" src=\"https:\/\/arasto.com\/wp-content\/uploads\/2022\/09\/word-image-5768-2.png\" srcset=\"https:\/\/arasto.com\/wp-content\/uploads\/2022\/09\/word-image-5768-2.png 500w, https:\/\/arasto.com\/wp-content\/uploads\/2022\/09\/word-image-5768-2-300x289.png 300w\" sizes=\"auto, (max-width: 500px) 100vw, 500px\" \/><\/p>\n<p dir=\"ltr\">The impurities provided in the following table represent Secondary Reference Standards (SRS) that are prepared in-house by synthesis or by isolation.\u00a0 Each SRS has undergone extensive characterization (IR, UV, 1HNMR, 13CNMR. Mass Spec) and determination of its purity and assay (HPLC).\u00a0 For specification of the SRS of those products that have a monograph, the SRS is compared with a pharmacopoeia Primary Reference Standard (UV, HPLC retention time).\u00a0 For specification of those products that do not have a monograph (known as House Primary Standard), we compare their UV \u03b5 or \u05d2\/<sub>max<\/sub>, IR major absorptions, <sup>1<\/sup>HNMR d(ppm), <sup>13<\/sup>CNMR \u00a0d(ppm) or HPLC retention time with values reported in the chemical literature for these compounds.<\/p>\n<p dir=\"ltr\">Nortriptyline hydrochloride Related Compounds<\/p>\n<table dir=\"ltr\">\n<tbody>\n<tr>\n<td><strong>Structure<\/strong><\/td>\n<td><strong>Chemical Name<\/strong><\/td>\n<td><strong>USP <\/strong><\/p>\n<p><strong>Code<\/strong><\/td>\n<td><strong>Arasto<\/strong><\/p>\n<p><strong> Code<\/strong><\/td>\n<\/tr>\n<tr>\n<td><img loading=\"lazy\" decoding=\"async\" width=\"200\" height=\"128\" class=\"wp-image-6445\" src=\"https:\/\/arasto.com\/wp-content\/uploads\/2022\/09\/word-image-5768-3.png\" \/><\/td>\n<td>\n<h1>Dibenzosuberone<\/h1>\n<\/td>\n<td>\n<h1>Amitriptyline Related Compound A<\/h1>\n<\/td>\n<td>\n<h1>Amitriptyline Related Compound A<\/h1>\n<\/td>\n<\/tr>\n<tr>\n<td><img loading=\"lazy\" decoding=\"async\" width=\"289\" height=\"210\" class=\"wp-image-6447\" src=\"https:\/\/arasto.com\/wp-content\/uploads\/2022\/09\/word-image-5768-4.png\" \/><\/td>\n<td>5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenzo[a,d]-cyclohepten-5-ol<\/td>\n<td>Amitriptyline Related Compound B<\/td>\n<td>Amitriptyline Related Compound B<\/td>\n<\/tr>\n<tr>\n<td><img loading=\"lazy\" decoding=\"async\" width=\"354\" height=\"247\" class=\"wp-image-6449\" src=\"https:\/\/arasto.com\/wp-content\/uploads\/2022\/09\/word-image-5768-5.png\" srcset=\"https:\/\/arasto.com\/wp-content\/uploads\/2022\/09\/word-image-5768-5.png 354w, https:\/\/arasto.com\/wp-content\/uploads\/2022\/09\/word-image-5768-5-300x209.png 300w\" sizes=\"auto, (max-width: 354px) 100vw, 354px\" \/><\/td>\n<td>3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-1-propanamine, hydrochloride<\/td>\n<td>Cyclobenzaprine Related Compound B<\/td>\n<td>Cyclobenzaprine Related Compound B<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p dir=\"ltr\"><strong>5. Reference Standards (ICH 3.2.S.5)<\/strong><\/p>\n<p dir=\"ltr\"><strong>5.1.\u00a0Primary and secondary reference standards (API)\u00a0\u00a0<\/strong><\/p>\n<p dir=\"ltr\">Primary Reference Standard for nortriptyline hydrochloride is available from United States Pharmacopoeia. We will use a Secondary Reference Standard (also known as House Standard or Working Standard) for direct control of all batches of nortriptyline hydrochloride.<\/p>\n<p dir=\"ltr\">As per ICH (Q7, 11.1) and ICH (Q6, 2.11, 3.2, 3.3) the Secondary Reference Standards must be examined for their identity by proof of structure (characterization), assay and purity and specification.\u00a0Furthermore, ICH Guideline on the Preparation of Common Technical Document (Q4M), requires that the data obtained from characterization, assay and purity and specification must be included in section 3.2.S.3.2 for Related Compounds and section 3.2.S.5 of the DMF for the API.\u00a0To this end, the Secondary Reference Standards of the API nortriptyline hydrochloride has undergone extensive characterization (UV, IR,\u00a0<sup>1<\/sup>\u00a0H NMR,\u00a0<sup>13<\/sup>C NMR, Mass Spec) to assure their identity, assay and purity (HPLC and\/or titration) and specification (comparison of its HPLC retention time and UV \u05d2\/<sub>max<\/sub>\u00a0with USP Primary Reference Standard.<\/p>\n<p dir=\"ltr\">The Secondary Reference Standard for nortriptyline HCl is produced from a released batch of nortriptyline HCl by subjecting it to an additional crystallization from the final solvent system used in the production of the API to avoid the possibility of other polymorph formation.<\/p>\n<h1 dir=\"ltr\">SPECIFICATION OF ANALYSIS<\/h1>\n<table dir=\"ltr\">\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Product: <\/strong>Nortriptyline Hydrochloride<\/td>\n<td colspan=\"2\"><strong>CAS No.:<\/strong> 894-71-3<\/td>\n<td><strong>Spec. No.: <\/strong>APC-QC-SPEC-390-00<\/td>\n<\/tr>\n<tr>\n<td colspan=\"2\"><strong>Issue Date: <\/strong>Apr, 2023<\/td>\n<td colspan=\"2\"><strong>Valid up to:<\/strong> Apr, 2024<\/td>\n<td><strong>Reference: <\/strong>USP44<\/td>\n<\/tr>\n<tr>\n<td><strong>Tests<\/strong><\/td>\n<td colspan=\"4\">\n<h2>Specifications<\/h2>\n<\/td>\n<\/tr>\n<tr>\n<td>Description<\/td>\n<td colspan=\"4\">White to off-white powder, having a slight, characteristic odor. Its solution (1 in 100) has a pH of about 5.<\/td>\n<\/tr>\n<tr>\n<td>Solubility<\/td>\n<td colspan=\"4\">Soluble in water and in chloroform; sparingly soluble in methanol; practically insoluble in ether, in benzene, and in most other organic solvents.<\/td>\n<\/tr>\n<tr>\n<td>Identification<\/td>\n<td colspan=\"4\">A: Infrared Absorption.<\/p>\n<p>B: The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay<\/p>\n<p>C:Chloride<\/td>\n<\/tr>\n<tr>\n<td>Loss on drying<\/td>\n<td colspan=\"4\">NMT 0.5% (at 105\u00b0C for 3h)<\/td>\n<\/tr>\n<tr>\n<td>Residue on ignition<\/td>\n<td colspan=\"4\">NMT 0.1%<\/td>\n<\/tr>\n<tr>\n<td>Residual Solvents<\/td>\n<td colspan=\"4\">Acetone: NMT 5000 ppm (Class III)<\/p>\n<p>Toluene: NMT 890 ppm (Class II)<\/td>\n<\/tr>\n<tr>\n<td>Organic Impurities (HPLC)<\/td>\n<td colspan=\"4\">Amitriptyline related compound A: NMT 0.05%<\/p>\n<p>Amitriptyline related compound B: NMT 0.15%<\/p>\n<p>Cyclobenzaprine related compound B: NMT 0.10%<\/p>\n<p>Any other individual impurity: NMT 0.10%<\/p>\n<p>Total impurities: NMT 0.2%<\/td>\n<\/tr>\n<tr>\n<td>Assay (HPLC)<\/td>\n<td colspan=\"4\">97.0% to 101.5% (on the dried basis)<\/td>\n<\/tr>\n<tr>\n<td colspan=\"3\"><strong>Prepared by:<\/strong> M. Shahbazi, B.Sc.Chem.<\/td>\n<td colspan=\"2\"><strong>Checked by:<\/strong> A. Forghani, B.Sc.Chem.<\/td>\n<\/tr>\n<tr>\n<td colspan=\"5\"><strong>Approved by:<\/strong> F. Javadizadeh, M.Sc.Chem.<\/td>\n<\/tr>\n<tr>\n<td colspan=\"5\"><strong>Storage:<\/strong> Preserve in tight, light-resistant containers.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Description (USP44\/BP2022) Drug Substance General Information (ICH 3.2.S.1) 1.1. Nomenclature (ICH 3.2.S.1.1) International Non-proprietary Name: Nortriptyline hydrochloride (Brand Name: Sensoval, Aventyl,\u00a0Pamelor, Norpress, Allegron, Noritren and Nortrilen) Compendial name:\u00a0 Nortriptyline Hydrochloride Chemical name:\u00a0 1-Propanamine, 3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-,hydrochloride;\u00a0 10, 11-Dihydro-N-methyl-5H-dibenzo [a,d] cycloheptene-\u03945,\u03b3-propylamine hydrochloride Arasto\u2019s code: NOR CAS Registry Number:\u00a0[894-71-3] Drug Substance General Information (ICH 3.2.S.1) 1.2. Structure (ICH 3.2.S.1.2) [&hellip;]<\/p>\n","protected":false},"featured_media":7100,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"product_cat":[72],"product_tag":[],"class_list":["post-6131","product","type-product","status-publish","has-post-thumbnail","hentry","product_cat-72"],"_links":{"self":[{"href":"https:\/\/arasto.com\/fa\/wp-json\/wp\/v2\/product\/6131","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/arasto.com\/fa\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/arasto.com\/fa\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/arasto.com\/fa\/wp-json\/wp\/v2\/comments?post=6131"}],"version-history":[{"count":3,"href":"https:\/\/arasto.com\/fa\/wp-json\/wp\/v2\/product\/6131\/revisions"}],"predecessor-version":[{"id":7102,"href":"https:\/\/arasto.com\/fa\/wp-json\/wp\/v2\/product\/6131\/revisions\/7102"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/arasto.com\/fa\/wp-json\/wp\/v2\/media\/7100"}],"wp:attachment":[{"href":"https:\/\/arasto.com\/fa\/wp-json\/wp\/v2\/media?parent=6131"}],"wp:term":[{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/arasto.com\/fa\/wp-json\/wp\/v2\/product_cat?post=6131"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/arasto.com\/fa\/wp-json\/wp\/v2\/product_tag?post=6131"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}